G × E interactions as a basis for toxicological uncertainty

Abstract

To transfer toxicological findings from model systems, e.g. animals, to humans, standardized safety factors are applied to account for intra-species and inter-species variabilities. An alternative approach would be to measure and model the actual compound-specific uncertainties. This biological concept assumes that all observed toxicities depend not only on the exposure situation (environment = E), but also on the genetic (G) background of the model (G × E). As a quantitative discipline, toxicology needs to move beyond merely qualitative G × E concepts. Research programs are required that determine the major biological variabilities affecting toxicity and categorize their relative weights and contributions. In a complementary approach, detailed case studies need to explore the role of genetic backgrounds in the adverse effects of defined chemicals. In addition, current understanding of the selection and propagation of adverse outcome pathways (AOP) in different biological environments is very limited. To improve understanding, a particular focus is required on modulatory and counter-regulatory steps. For quantitative approaches to address uncertainties, the concept of “genetic” influence needs a more precise definition. What is usually meant by this term in the context of G × E are the protein functions encoded by the genes. Besides the gene sequence, the regulation of the gene expression and function should also be accounted for. The widened concept of past and present “gene expression” influences is summarized here as Ge. Also, the concept of “environment” needs some re-consideration in situations where exposure timing (Et) is pivotal: prolonged or repeated exposure to the insult (chemical, physical, life style) affects Ge. This implies that it changes the model system. The interaction of Ge with Et might be denoted as Ge × Et. We provide here general explanations and specific examples for this concept and show how it could be applied in the context of New Approach Methodologies (NAM).

New approach methods to assess developmental and adult neurotoxicity for regulatory use: a PARC work package 5 project

“…Such work will include considerations on how DNT-IVB data may be used in the context of an IATA or weight of evidence for hazard and risk characterization. This links seamlessly to other PARC work packages that provide information on physiologically-based kinetic (PBK) modelling to convert IVB concentrations to predicted in vivo doses, and to risk assessment specialists that need to consider how the predicted doses can be used to set safe exposure thresholds by, for example, considering modulatory factors in AOP or by considering variabilities and specific sensitivities in exposed populations ( Schmeisser et al, 2023 ; Suciu et al, 2023 ).…”

Revolutionizing developmental neurotoxicity testing – a journey from animal models to advanced in vitro systems

“…Another line of work is to use brain organoids to study gene-environment interactions (Butera et al, 2023;Suciu et al, 2023a). We cannot explain the enormous increase in ASD (Tab.…”

A network toxicology approach for mechanistic modelling of nanomaterial hazard and adverse outcomes

“…Indeed, in contemporary toxicology, the observed toxicities are often assumed to be primarily influenced by the dose and the intrinsic properties of the exposure, while the features of the exposed biological system (test system) are referred to as "biological descriptors" of the exposure [4]. However, understanding the system effects is important for selecting relevant models and to correctly characterise the hazard [5]. Thus far, a plethora of omics (e.g., transcriptomics, proteomics) data have been generated to investigate the molecular responses to compounds in various test systems [6].…”